Find therapies in clinical trials near you – page 769

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

Long-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials

Long-Term Safety Study of Azacitidine for Patients with Blood Disorders Who Previously Participated in Azacitidine Clinical Trials

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Study of Zanubrutinib and Tacrolimus for Patients with Primary Membranous Nephropathy

Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Study on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant